The Chung Lab at USC has developed a nanoparticle that attaches to immune cells, allowing it to target lymph nodes—a vital indicator of cancer metastasis—and enhance MRI detection, potentially revolutionizing cancer screenings by improving early detection of metastasis without invasive biopsies.